Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages

被引:53
作者
Halvorsen, Bente [1 ,2 ,3 ]
Espeland, Martine Z. [1 ,2 ]
Andersen, Geir Oystein [4 ,5 ]
Yndestad, Arne [1 ,2 ,3 ,5 ]
Sagen, Ellen Lund [1 ,2 ]
Rashidi, Azita [1 ]
Knudsen, Eva C. [4 ,6 ]
Skjelland, Mona [10 ]
Skagen, Karolina R. [10 ]
Krohg-Sorensen, Kirsten [11 ]
Holm, Sverre [1 ]
Ritschel, Vibeke [4 ,6 ]
Holven, Kirsten B. [7 ]
Biessen, Erik A. L. [8 ]
Aukrust, Pal [1 ,2 ,3 ,9 ]
Dahl, Tuva B. [1 ,2 ,3 ]
机构
[1] Oslo Univ Hosp, Rikshosp, Internal Med Res Inst, Oslo, Norway
[2] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway
[3] Univ Oslo, KG Jebsen Inflammat Res Ctr, Oslo, Norway
[4] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway
[5] Univ Oslo, Ctr Heart Failure, Oslo, Norway
[6] Oslo Univ Hosp Ulleval, Ctr Clin Heart Res, Oslo, Norway
[7] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway
[8] Maastricht Univ, Med Ctr, Expt Vasc Pathol Grp, Dept Pathol,CARIM, NL-6200 MD Maastricht, Netherlands
[9] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, Rikshosp, Oslo, Norway
[10] Oslo Univ Hosp, Dept Neurol, Rikshosp, Oslo, Norway
[11] Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, Rikshosp, Oslo, Norway
关键词
Macrophage polarization; Atherosclerosis; NAMPT; Acute coronary syndrome; Inflammation; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; ATHEROSCLEROSIS; POLARIZATION; VISFATIN; ACTIVATION; PHENOTYPE; CULTURE; ROLES; CELLS; SERUM;
D O I
10.1016/j.atherosclerosis.2015.09.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: The aim of the present study were to elucidate the role of NAMPT in atherosclerosis, by examine NAMPT expression in peripheral blood mononuclear cells (PBMC) in patients with coronary artery disease (CAD) and healthy controls and by examining the regulation and effect of NAMPT on macrophage polarization, hypothesizing that it could influence the polarization to inflammatory and resolving macrophages. Method and Results: We analyzed RNA levels of NAMPT in PBMC from CAD and healthy controls and found NAMPT to be increased in PBMC from patients with acute coronary syndrome (n = 39) compared to healthy controls (n = 20) and patients with stable CAD (n = 22). Within the PBMC NAMPT was correlated to several inflammatory cytokines and the antioxidant enzyme superoxide dismutase 2. In vitro cell experiments revealed that NAMPT is increased both intracellular and extracellular in inflammatory M1 macrophages compared to in anti-inflammatory M2 macrophages. In addition, inhibiting NAMPT enzymatic activity inhibited M1 polarization in macrophages. Conclusion: Based on our in vivo and in vitro findings we suggest that NAMPT could contribute to systemic and plaque inflammation in atherosclerotic disorders at least partly through effect on macrophages. (C) 2015 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:204 / 210
页数:7
相关论文
共 34 条
  • [21] Exploring the full spectrum of macrophage activation
    Mosser, David M.
    Edwards, Justin P.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2008, 8 (12) : 958 - 969
  • [22] Munder M, 1998, J IMMUNOL, V160, P5347
  • [23] Points of control in inflammation
    Nathan, C
    [J]. NATURE, 2002, 420 (6917) : 846 - 852
  • [24] Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice
    Nencioni, Alessio
    da Silva, Rafaela F.
    Fraga-Silva, Rodrigo A.
    Steffens, Sabine
    Fabre, Mathias
    Bauer, Inga
    Caffa, Irene
    Magnone, Mirko
    Sociali, Giovanna
    Quercioli, Alessandra
    Pelli, Graziano
    Lenglet, Sebastien
    Galan, Katia
    Burger, Fabienne
    Calvo, Sara Vazquez
    Bertolotto, Maria
    Bruzzone, Santina
    Ballestrero, Alberto
    Patrone, Franco
    Dallegri, Franco
    Santos, Robson A. S.
    Stergiopulos, Nikolaos
    Mach, Francois
    Vuilleumier, Nicolas
    Montecucco, Fabrizio
    [J]. THROMBOSIS AND HAEMOSTASIS, 2014, 111 (02) : 308 - 322
  • [25] ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
    Steg, Ph. Gabriel
    James, Stefan K.
    Atar, Dan
    Badano, Luigi P.
    Blomstrom-Lundqvist, Carina
    Borger, Michael A.
    Di Mario, Carlo
    Dickstein, Kenneth
    Ducrocq, Gregory
    Fernandez-Aviles, Francisco
    Gershlick, Anthony H.
    Giannuzzi, Pantaleo
    Halvorsen, Sigrun
    Huber, Kurt
    Juni, Peter
    Kastrati, Adnan
    Knuuti, Juhani
    Lenzen, Mattie J.
    Mahaffey, Kenneth W.
    Valgimigli, Marco
    van't Hof, Arnoud
    Widimsky, Petr
    Zahger, Doron
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 (20) : 2569 - 2619
  • [26] Distribution of macrophage polarization markers in human atherosclerosis
    Stoger, J. Lauran
    Gijbels, Marion J. J.
    van der Velden, Saskia
    Manca, Marco
    van der Loos, Chris M.
    Biessen, Erik A. L.
    Daemen, Mat J. A. P.
    Lutgens, Esther
    de Winther, Menno P. J.
    [J]. ATHEROSCLEROSIS, 2012, 225 (02) : 461 - 468
  • [27] Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences
    Stout, RD
    Jiang, CC
    Matta, B
    Tietzel, I
    Watkins, SK
    Suttles, J
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (01) : 342 - 349
  • [28] Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice
    Swirski, Filip K.
    Wildgruber, Moritz
    Ueno, Takuya
    Figueiredo, Jose-Luiz
    Panizzi, Peter
    Iwamoto, Yoshiko
    Zhang, Elizabeth
    Stone, James R.
    Rodriguez, Elisenda
    Chen, John W.
    Pittet, Mikael J.
    Weissleder, Ralph
    Nahrendorf, Matthias
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (07) : 2627 - 2634
  • [29] Macrophage death and defective inflammation resolution in atherosclerosis
    Tabas, Ira
    [J]. NATURE REVIEWS IMMUNOLOGY, 2010, 10 (01) : 36 - 46
  • [30] Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI [10.1016/j.clinbiochem.2012.10.036, 10.1016/j.jacc.2012.08.001, 10.1016/j.gheart.2012.08.001, 10.1161/CIR.0b013e31826e1058, 10.1093/eurheartj/ehs184, 10.1016/j.gheart.2018.08.004, 10.5603/KP.2018.0203]